Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Larry H. Bernstein, MD, FCAP, Curator
http://pharmaceuticalintelligence/7/6/2014/Genomics, Proteomics and standards
This article is a look at where the biomedical research sciences are in developing standards for development in the near term.
Let’s Not Wait for the FDA: Raising the Standards of Biomarker Development – A New Series
published by Theral Timpson on Tue, 07/01/2014 – 15:03
We talk a lot on this show about the potential of personalized medicine. Never before have we learned at such breakneck speed just how our bodies function. The pace of biological research staggers the mind and hints at a time when we will “crack the code” of the system that is homo sapiens, going from picking the low hanging fruit to a more rational approach. The high tech world has put at the fingertips of biologists just the tools to do it. There is plenty of compute, plenty of storage available to untangle, or decipher the human…
Vezi articolul original 1.872 de cuvinte mai mult
No comments yet... Be the first to leave a reply!